Blue Owl Capital Holdings as of March 31, 2024
Portfolio Holdings for Blue Owl Capital Holdings
Blue Owl Capital Holdings holds 45 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Robinhood Mkts Com Cl A (HOOD) | 10.8 | $54M | 4.2M | 12.74 | |
| Cullinan Oncology (CGEM) | 10.0 | $50M | 2.9M | 17.04 | |
| Pliant Therapeutics (PLRX) | 8.9 | $45M | 3.0M | 14.90 | |
| Engene Holdings (ENGN) | 8.3 | $42M | 2.5M | 16.95 | |
| Tourmaline Bio (TRML) | 6.4 | $32M | 1.4M | 22.10 | |
| Owl Rock Capital Corporation (OBDC) | 6.3 | $32M | 2.0M | 15.38 | |
| Klaviyo Com Ser A (KVYO) | 6.1 | $31M | 1.2M | 25.48 | |
| Larimar Therapeutics (LRMR) | 6.1 | $30M | 4.0M | 7.59 | |
| Acelyrin (SLRN) | 3.8 | $19M | 2.8M | 6.75 | |
| Evercommerce (EVCM) | 3.1 | $16M | 1.6M | 9.42 | |
| Repare Therapeutics Ord (RPTX) | 2.9 | $15M | 3.1M | 4.71 | |
| Ultragenyx Pharmaceutical (RARE) | 2.5 | $13M | 268k | 46.69 | |
| Keros Therapeutics (KROS) | 2.3 | $11M | 173k | 66.20 | |
| Inozyme Pharma (INZY) | 1.9 | $9.7M | 1.3M | 7.66 | |
| Disc Medicine (IRON) | 1.9 | $9.7M | 155k | 62.26 | |
| Sagimet Biosciences Com Ser A (SGMT) | 1.8 | $9.1M | 1.7M | 5.42 | |
| Toast Cl A (TOST) | 1.6 | $8.0M | 323k | 24.92 | |
| E2open Parent Holdings Com Cl A (ETWO) | 1.5 | $7.3M | 1.7M | 4.44 | |
| Mineralys Therapeutics (MLYS) | 1.4 | $7.0M | 541k | 12.91 | |
| Compass Therapeutics (CMPX) | 1.1 | $5.6M | 2.8M | 1.98 | |
| Ikena Oncology (IKNA) | 1.1 | $5.5M | 3.9M | 1.42 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.0 | $5.0M | 100k | 50.23 | |
| Dell Technologies SHS (DELL) | 0.9 | $4.7M | 41k | 114.11 | |
| Omega Therapeutics Common Stock (OMGA) | 0.8 | $3.9M | 1.1M | 3.65 | |
| Aquestive Therapeutics (AQST) | 0.7 | $3.7M | 875k | 4.26 | |
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.7 | $3.6M | 490k | 7.29 | |
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $3.6M | 13k | 267.04 | |
| Black Diamond Therapeutics (BDTX) | 0.7 | $3.5M | 695k | 5.07 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.7 | $3.3M | 734k | 4.49 | |
| Immunovant (IMVT) | 0.6 | $3.2M | 100k | 32.31 | |
| Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.5 | $2.7M | 511k | 5.20 | |
| Ovid Therapeutics (OVID) | 0.5 | $2.6M | 865k | 3.05 | |
| Starwood Property Trust SHS (BRZE) | 0.5 | $2.4M | 116k | 20.33 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.4 | $1.8M | 341k | 5.35 | |
| Snowflake SHS (SNOW) | 0.3 | $1.3M | 7.8k | 161.60 | |
| Gitlab (GTLB) | 0.2 | $1.2M | 21k | 58.32 | |
| Blend Labs Cl A (BLND) | 0.2 | $1.2M | 362k | 3.25 | |
| Gohealth Com Cl A (GOCO) | 0.2 | $875k | 83k | 10.51 | |
| Desktop Metal Com Cl A | 0.1 | $660k | 750k | 0.88 | |
| Rallybio Corp (RLYB) | 0.1 | $648k | 350k | 1.85 | |
| Enliven Therapeutics (ELVN) | 0.1 | $440k | 25k | 17.59 | |
| Precision Biosciences Com New (DTIL) | 0.1 | $274k | 20k | 13.56 | |
| Fathom Digital Mfg Corp Cl A Com | 0.0 | $231k | 50k | 4.61 | |
| Uber Technologies (UBER) | 0.0 | $79k | 24k | 3.30 | |
| Plum Acquisition Corp Iii *w Exp 03/31/202 (PLMJW) | 0.0 | $0 | 667k | 0.00 |
